Clinical Trials Directory

Trials / Terminated

TerminatedNCT04364126

Home Blood Pressure Monitoring in Kidney Transplant Recipients

Home Blood Pressure Monitoring in Kidney Transplant Recipients to Alleviate Hypertension - a Pragmatic, Registry-based, Randomized Controlled Study

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
21 (actual)
Sponsor
Oslo University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Randomized controlled study of home blood pressure monitoring in kidney transplant recipients.

Detailed description

Adult kidney transplant recipients (n=458) will be randomized 1:1 to standard-of-care (SOC) or home blood pressure measurement (HBPM). The SOC group will target office blood pressure \<130/80 mmHg. The HBPM group will measure BP at home, twice morning and evening for (3-)7 days before routine clinical visits (ideally 28 measurements); the mean value from day 2-7 is used; target home mean BP is \< 125/80 mmHg.

Conditions

Interventions

TypeNameDescription
DEVICEHome blood pressure apparatusTarget \<125/80 mmHg
OTHERClinic blood pressureTarget \<130/80 mmHg

Timeline

Start date
2022-12-15
Primary completion
2025-02-03
Completion
2026-01-01
First posted
2020-04-27
Last updated
2026-01-21

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT04364126. Inclusion in this directory is not an endorsement.